As a reliable medical billing and coding company, we keep track of industry updates to help physicians report their services correctly. One of the latest developments is the announcement of a new set of CPT codes by the American Medical Association (AMA) to streamline reporting of immunizations for the novel coronavirus.

At the time of this writing, up to 55 million people across the globe have tested positive for the novel coronavirus and the pandemic has caused an estimated 1.5 deaths. The United States accounts for over 11 million cases and more than 250,000 deaths. The world heaved a sigh of relief with Pfizer’s announcing that they have produced an effective vaccine for COVID-19.

Following Pfizer’s announcement that the vaccine has proven strongly protective in a preliminary analysis of Phase 3 data, with efficacy of over 90%, the American Medical Association (AMA) worked with the Centers for Disease Control and Prevention (CDC) to develop a new set of CPT codes for documenting it. FDA approval of the vaccine is expected by the end of November, and if things go as planned, vaccinations and the use of the new codes to report them will begin in December.

The AMA has launched six Category I codes for documenting the COVID-19 vaccine (0001A, 0002A, 0011A, 0012A, 91300, 91301), as well as new and revised guidelines and parenthetical notes, and a new Appendix Q.

“These CPT codes are unique for each of two coronavirus vaccines, as well as administration codes unique to each such vaccine,” according to a write-up on the AMA website. “The new CPT codes clinically distinguish each coronavirus vaccine for better tracking, reporting, and analysis that supports data-driven planning and allocation.”

The long descriptors of the new codes are:

0001A: Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative-free, 30 mcg/0.3mL dosage, diluent reconstituted; first dose
0002A: Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative-free, 30 mcg/0.3mL dosage, diluent reconstituted; second dose
0011A: Immunization administration by intramuscular injection of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative-free, 100 mcg/0.5mL dosage; first dose
0012A: Immunization administration by intramuscular injection of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative-free, 100 mcg/0.5mL dosage; second dose
91300: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative-free, 30 mcg/0.3mL dosage, diluent reconstituted, for intramuscular use
91301: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5mL dosage, for intramuscular use

The AMA also provides specific guidelines on the use of the new COVID-19 immunization codes: “Report 0001A, 0002A, 0011A, 0012A for immunization administration of SARS-CoV-2 (Coronavirus disease [COVID19]) vaccines only. Each administration code is specific to each individual vaccine product (e.g., 91300, 91301), the dosage schedule (e.g., first dose, second dose), and counseling, when performed. The appropriate administration code is chosen based on the type of vaccine and the specific dose number the patient receives in the schedule. For example, 0012A is reported for the second dose of vaccine 91301.”

HIT Consultant notes that the level of level of specificity the specificity of the vaccine administration CPT code will enable tracking of each vaccine dose. For instance, if the vaccine product is given to the patient free of cost and not reported, the CPT codes will allow the actual work of administering the vaccine to be reported, as well as the counseling provided to patients or caregivers and updating of the electronic record.

These new vaccine-specific CPT codes will be available for use and effective as each new coronavirus vaccine receives Emergency Use Authorization or approval from the Food and Drug Administration. Reporting COVID-19 immunizations with the new CPT codes and guidelines will be much easier with the help of an experienced medical coding company.